Jun
19
NASPAG NEXPLANON UPDATE - BY AUGUST 23, 2026
- The FDA now requires a Risk Evaluation and Mitigation Strategy (REMS) for NEXPLANON to reduce complications from improper insertion or removal. Organon’s existing Clinical Training Program (CTP) has been incorporated into the new REMS.
- All HCPs who insert NEXPLANON must be REMS-certified by August 23, 2026. After this date, uncertified providers will lose access to NEXPLANON for insertion procedures.
- Active providers (completed CTP + inserted/removed NEXPLANON in the past 3 years):
Review the Prescribing Information/Instructions for Use and Healthcare Provider Guide, then complete and submit the online Knowledge Assessment + Enrollment Form at www.NEXPLANONREMS.com (or fax to 1-833-430-2807). No repeat CTP required. - Inactive or new providers: Complete the same steps above plus the Didactic Training and In-Person Practical Training (with Competency Checklist) provided by Organon.
Next step:
Visit www.NEXPLANONREMS.com or scan the QR code on the attached flyer to begin certification.
Questions? Call the NEXPLANON REMS line at 1-833-697-7367.
Heavy menstrual bleeding (HMB) is a common complaint in young women in the general population and is associated with disruptions in physical, mental, and social well-being. This study aimed to describe the prevalence of HMB among adolescents with...
PCOS is a common disorder associated with adverse reproductive, cardiometabolic, and psychosocial outcomes that impair quality of life. The 2023 International Polycystic Ovary Syndrome guideline represents an important advance in clinical care...
Phase 2 research data by University of Oxford and Serac Healthcare Limited, published in 
I’m honored and excited to step into the role of President for the next two years. NASPAG has been the core foundation of my professional life, and I’m grateful for the trust you’ve placed in me to lead our brilliant and vibrant NASPAG community.
